Clinical trials in Ukraine have experienced intense disruption as a result of Russia’s invasion, but companies such as Oximio have managed to find ways to continue with operations. Credit: ProStockStudio via Shutterstock.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.